Yufeng Hong

USPTO Granted Patents = 25 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 201(Granted Patents)

Company Filing History:

10 out of 174

Agouron Pharmaceuticals, Inc.

Concortis Biosystems, Corp.

Argusina Bioscience Inc.

patent

7. 1 out of 4,177

Abbott Laboratories Corporation

patents

8. 1 out of 1

Concortis Biosystems, Corp., a Wholly Owned Subsidiary of Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

patents

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12115228 - Drug-conjugates, conjugation methods, and uses thereof (2024-10-15),

2. 11987622 - Drug-conjugates with a targeting molecule and two different drugs (2024-05-21),

3. 10967071 - Drug-conjugates, conjugation methods, and uses thereof (2021-04-06),

4. 10836821 - Drug-conjugates with a targeting molecule and two different drugs (2020-11-17),

5. 9981046 - Drug-conjugates, conjugation methods, and uses thereof (2018-05-29),

6. 9884127 - Drug-conjugates, conjugation methods, and uses thereof (2018-02-06),

7. 9801951 - Drug-conjugates, conjugation methods, and uses thereof (2017-10-31),

8. 8999981 - [object Object] (2015-04-07),

9. 8748412 - Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators (2014-06-10),

10. 8530652 - Pyrrolopyrazoles, potent kinase inhibitors (2013-09-10),

11. 8114871 - 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives (2012-02-14),

12. 8067591 - Pyrrolopyrazole, potent kinase inhibitors (2011-11-29),

13. 7928226 - Salts and polymorphs of a VEGF-R inhibitor (2011-04-19),

14. 7923457 - Quinoline derivatives (2011-04-12),

15. 7884117 - Carbonylamino pyrrolopyrazoles, potent kinase inhibitors (2011-02-08),

Sure, here is the article about inventor Yufeng Hong:

Title: Unveiling the Inventive Journey of Yufeng Hong in the World of Drug-Conjugates

Introduction:

Yufeng Hong, a prolific inventor based in San Diego, CA (US), has made significant contributions to the field of drug-conjugates with his innovative patents and research endeavors.

Latest Patents:

Yufeng Hong has accumulated an impressive portfolio of 23 patents, with his latest patents focusing on drug-conjugates, conjugation methods, and their diverse applications. Among them are groundbreaking inventions such as drug-conjugates with a targeting molecule and two different drugs, revolutionizing the field of antibody drug conjugates (ADCs).

Career Highlights:

With a rich professional background, Yufeng Hong has honed his expertise while working at renowned pharmaceutical companies such as Agouron Pharmaceuticals, Inc. and Pfizer Corporation. His experiences in these esteemed organizations have undoubtedly played a pivotal role in shaping his inventive mindset and fueling his passion for innovation.

Collaborations:

Throughout his career, Yufeng Hong has had the privilege of collaborating with exceptional individuals in the field, including esteemed coworkers like Haitao Li and Eileen Valenzuela Tompkins. These collaborations have not only enriched his professional network but have also fostered a culture of creativity and knowledge exchange.

Conclusion:

In conclusion, Yufeng Hong's dedication to pioneering advancements in drug-conjugates underscores his commitment to transforming the landscape of modern medicine. His relentless pursuit of innovation and collaborative spirit continue to inspire peers and aspiring inventors alike in the ever-evolving realm of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.